BridgeMD
New treatment option for Mild Cognitive Impairment
Official title Effects of Shuttle Balance Training on Balance , Gait and Postural Control in Children With Mild Cognitive Impairment
ClinicalTrials.gov ID: NCT06974890
What this study is testing
- What it's testing
- This study aims to investigate the impact of Shuttle Balance Training (SBT) on balance, gait, and postural control among children diagnosed with mild cognitive impairment (MCI). Mild cognitive impairment in children often manifests as challenges in cognitive processing, motor coordination, and daily activities that involve balance and movement.
- Time commitment: about 12 weeks
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 6 to 12
You may be able to join if
- Children with mild cognitive impairment (50-70%IQ)
- Age group from 6 to 12 years
- Both male and female
- Children must have the physical and cognitive ability to engage in the activities
- Children should be in generally good health, without severe medical conditions or orthopedic issues
You likely can't join if
- Children with severe cognitive impairment
- Children who have severe neurological disorders
- Children with visual and auditory impairment
- Children with severe sensory processing disorders
The study team makes the final eligibility decision.
Where it's taking place
- Lahore, Punjab Province, Pakistan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 12 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 6 years to 12 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Lahore, Punjab Province, Pakistan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.